Hong Kong Renewable Energy Stock News

InSilico Medicine Cayman TopCo (SEHK:3696), an AI-focused biotech drug developer, has attracted attention after a 27.2% move over the past week, prompting investors to reassess its recent share performance and underlying business profile. See our latest analysis for InSilico Medicine Cayman TopCo. The recent 27.22% 7 day share price return comes after a relatively muted year to date share price return of 1.49%. Momentum now looks to be picking up from a low base while the stock trades at...

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...

When you buy a stock there is always a possibility that it could drop 100%. But on the bright side, you can make far...

If we want to find a stock that could multiply over the long term, what are the underlying trends we should look for...

When close to half the companies operating in the Consumer Services industry in Hong Kong have price-to-sales ratios...

The FEG Holdings Corporation Limited ( HKG:1413 ) share price has fared very poorly over the last month, falling by a...

Tianli International Holdings Limited ( HKG:1773 ) just reported some strong earnings, and the market reacted...

REM Group (Holdings) Limited ( HKG:1750 ) shares have continued their recent momentum with a 27% gain in the last month...

The recent earnings posted by China New Higher Education Group Limited ( HKG:2001 ) were solid, but the stock didn't...

Key Insights Shenwan Hongyuan (H.K.)'s significant public companies ownership suggests that the key decisions are...

First Shanghai Investments Limited ( HKG:227 ) shareholders might be concerned after seeing the share price drop 18% in...

Unfortunately for some shareholders, the Xinhua Lande Scitech Co., Limited ( HKG:8106 ) share price has dived 27% in...

Even though i-CABLE Communications Limited ( HKG:1097 ) has fallen by 13% over the past week , insiders who sold...

Shareholders appeared unconcerned with AV Concept Holdings Limited's ( HKG:595 ) lackluster earnings report last week...

Key Insights The considerable ownership by private companies in Zero Fintech Group indicates that they collectively...

Postal Savings Bank of China (SEHK:1658) is in the spotlight after President Liu Jianjun resigned upon reaching retirement age, with the board backing Lu Wei as his successor, subject to regulatory approval. See our latest analysis for Postal Savings Bank of China. The leadership reshuffle comes after a period where momentum in the share price has cooled, with a 1-day share price return of 0.58% and a year to date share price return of a 0.76% decline. This comes even as the 1-year total...

NetEase (SEHK:9999) is in focus after announcing the retirement of Yingfeng Ding, Executive Vice President and head of its Interactive Entertainment Group, a central figure in the company’s online games and R&D operations. See our latest analysis for NetEase. The retirement news lands at a time when momentum has cooled slightly, with a 30 day share price return of 5.14% but a 90 day share price decline of 4.34%. However, the 1 year total shareholder return of 71.05% and 3 year total...

Sands China (SEHK:1928) is back in focus after being confirmed as the Official Promoter for the NBA China Games 2026 at The Venetian Arena in Macao, featuring the Dallas Mavericks and Houston Rockets. See our latest analysis for Sands China. Alongside the NBA China Games announcement and the renewal of its shared services agreement with Las Vegas Sands Corp. through 2028, Sands China’s recent share price performance has been mixed. A 1-day share price return of 0.96% contrasts with a 30-day...

Grand Pharmaceutical Group has announced that Neffy®, the world’s first adrenaline nasal spray, has obtained drug registration approval from China’s National Medical Products Administration for emergency treatment of type I allergic reactions in adults and children over 30kg, with exclusive commercialization rights in Mainland China and planned localized production within 24 months. This marks the first non-injectable adrenaline treatment approved in China, potentially broadening real-world...

Key Insights Significant control over JD Health International by public companies implies that the general public has...

Poly Property Services (HKG:6049) has had a rough month with its share price down 4.1%. However, stock prices are...

Key Insights Sunny Optical Technology (Group)'s estimated fair value is HK$95.31 based on 2 Stage Free Cash Flow to...

What Prada’s recent share performance tells you Prada (SEHK:1913) has drawn attention after a period of weaker share performance, with the stock down over the past month, past 3 months and year. This has prompted investors to reassess expectations around its current valuation. See our latest analysis for Prada. At a share price of HK$43.30, Prada’s weaker recent share price returns, including a 90 day share price return decline of 7.32%, sit alongside a 1 year total shareholder return decline...

To find a multi-bagger stock, what are the underlying trends we should look for in a business? Ideally, a business will...